174 related articles for article (PubMed ID: 38396907)
1. Autocrine Regulation of Interleukin-6 via the Activation of STAT3 and Akt in Cardiac Myxoma Cells.
Jougasaki M; Takenoshita Y; Umebashi K; Yamamoto M; Sudou K; Nakashima H; Sonoda M; Kinjo T
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396907
[TBL] [Abstract][Full Text] [Related]
2. Persistent activation of signal transducer and activator of transcription 3 via interleukin-6 trans-signaling is involved in fibrosis of endometriosis.
Matsuzaki S; Pouly JL; Canis M
Hum Reprod; 2022 Jun; 37(7):1489-1504. PubMed ID: 35551394
[TBL] [Abstract][Full Text] [Related]
3. Regulation of soluble interleukin-6 (IL-6) receptor release from corneal epithelial cells and its role in the ocular surface.
Sugaya S; Sakimoto T; Shoji J; Sawa M
Jpn J Ophthalmol; 2011 May; 55(3):277-282. PubMed ID: 21523377
[TBL] [Abstract][Full Text] [Related]
4. Melittin enhances apoptosis through suppression of IL-6/sIL-6R complex-induced NF-κB and STAT3 activation and Bcl-2 expression for human fibroblast-like synoviocytes in rheumatoid arthritis.
Kim SK; Park KY; Yoon WC; Park SH; Park KK; Yoo DH; Choe JY
Joint Bone Spine; 2011 Oct; 78(5):471-7. PubMed ID: 21354845
[TBL] [Abstract][Full Text] [Related]
5. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
Hashizume M; Hayakawa N; Mihara M
Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965
[TBL] [Abstract][Full Text] [Related]
6. Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells.
Huang WL; Yeh HH; Lin CC; Lai WW; Chang JY; Chang WT; Su WC
Mol Cancer; 2010 Dec; 9():309. PubMed ID: 21122157
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas.
Adachi Y; Aoki C; Yoshio-Hoshino N; Takayama K; Curiel DT; Nishimoto N
Int J Cancer; 2006 Sep; 119(6):1303-11. PubMed ID: 16642474
[TBL] [Abstract][Full Text] [Related]
8. IL-6 and sIL-6R induces STAT3-dependent differentiation of human VSMCs into osteoblast-like cells through JMJD2B-mediated histone demethylation of RUNX2.
Kurozumi A; Nakano K; Yamagata K; Okada Y; Nakayamada S; Tanaka Y
Bone; 2019 Jul; 124():53-61. PubMed ID: 30981888
[TBL] [Abstract][Full Text] [Related]
9. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells.
Nishimura R; Moriyama K; Yasukawa K; Mundy GR; Yoneda T
J Bone Miner Res; 1998 May; 13(5):777-85. PubMed ID: 9610741
[TBL] [Abstract][Full Text] [Related]
10.
Zongfei J; Rongyi C; Xiaomeng C; Lili M; Lingying M; Xiufang K; Xiaomin D; Zhuojun Z; Huiyong C; Ying S; Lindi J
Front Immunol; 2020; 11():1272. PubMed ID: 32733444
[No Abstract] [Full Text] [Related]
11. Pro-fibrotic effect of IL-6 via aortic adventitial fibroblasts indicates IL-6 as a treatment target in Takayasu arteritis.
Kong X; Ma L; Ji Z; Dong Z; Zhang Z; Hou J; Zhang S; Ma L; Jiang L
Clin Exp Rheumatol; 2018; 36(1):62-72. PubMed ID: 28770707
[TBL] [Abstract][Full Text] [Related]
12. Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes.
Choe JY; Park KY; Park SH; Lee SI; Kim SK
Arthritis Res Ther; 2013 Feb; 15(1):R26. PubMed ID: 23406906
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
Mimata Y; Kamataki A; Oikawa S; Murakami K; Uzuki M; Shimamura T; Sawai T
Int J Rheum Dis; 2012 Feb; 15(1):36-44. PubMed ID: 22324945
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
15. Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing.
Ebihara N; Matsuda A; Nakamura S; Matsuda H; Murakami A
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8549-57. PubMed ID: 21989726
[TBL] [Abstract][Full Text] [Related]
16. Triptolide Inhibits Expression of Inflammatory Cytokines and Proliferation of Fibroblast-like Synoviocytes Induced by IL-6/sIL-6R-Mediated JAK2/STAT3 Signaling Pathway.
Lin JJ; Tao K; Gao N; Zeng H; Wang DL; Yang J; Weng J
Curr Med Sci; 2021 Feb; 41(1):133-139. PubMed ID: 33582917
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6/soluble interleukin-6 receptor signaling attenuates proliferation and invasion, and induces morphological changes of a newly established pleomorphic malignant fibrous histiocytoma cell line.
Nakanishi H; Yoshioka K; Joyama S; Araki N; Myoui A; Ishiguro S; Ueda T; Yoshikawa H; Itoh K
Am J Pathol; 2004 Aug; 165(2):471-80. PubMed ID: 15277221
[TBL] [Abstract][Full Text] [Related]
18. Human T-cell leukemia virus type-I Tax induces expression of interleukin-6 receptor (IL-6R): Shedding of soluble IL-6R and activation of STAT3 signaling.
Horiuchi S; Yamamoto N; Dewan MZ; Takahashi Y; Yamashita A; Yoshida T; Nowell MA; Richards PJ; Jones SA; Yamamoto N
Int J Cancer; 2006 Aug; 119(4):823-30. PubMed ID: 16557588
[TBL] [Abstract][Full Text] [Related]
19. Shedding of the interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts.
Vermes C; Jacobs JJ; Zhang J; Firneisz G; Roebuck KA; Glant TT
J Biol Chem; 2002 May; 277(19):16879-87. PubMed ID: 11884403
[TBL] [Abstract][Full Text] [Related]
20. Role of soluble interleukin-6 receptor in inflamed gingiva for binding of interleukin-6 to gingival fibroblasts.
Naruishi K; Takashiba S; Chou HH; Arai H; Nishimura F; Murayama Y
J Periodontal Res; 1999 Aug; 34(6):296-300. PubMed ID: 10633884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
